Combination of gemcitabine and paclitaxel as second-line chemotherapy for advanced urothelial carcinoma.

@article{Suyama2009CombinationOG,
  title={Combination of gemcitabine and paclitaxel as second-line chemotherapy for advanced urothelial carcinoma.},
  author={Takahito Suyama and Takeshi Ueda and Satoshi Fukasawa and Yusuke Imamura and Kazuyoshi Nakamura and Kyoko Miyasaka and Tomokazu Sazuka and Ken-ichi Egoshi and Naoki Nihei and Masaaki Hamano and Tomohiko Ichikawa and Masayuki Maruoka},
  journal={Japanese journal of clinical oncology},
  year={2009},
  volume={39 4},
  pages={
          244-50
        }
}
OBJECTIVE The aim of this study was to evaluate the efficacy and toxicities of the gemcitabine and paclitaxel combination regimen as second-line chemotherapy for patients with advanced or metastatic urothelial carcinoma (UC) who have previously been treated with platinum-based chemotherapy for the metastatic disease. METHODS Thirty-three patients with advanced or metastatic UC who had received platinum-based chemotherapy were treated with an outpatient gemcitabine and paclitaxel combination… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 30 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 43 REFERENCES

Clinical cancer advances

J Gralow, RF Ozols, +3 authors EP Winer
  • 2007

Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinoma.

  • International journal of urology : official journal of the Japanese Urological Association
  • 2007
VIEW 1 EXCERPT